Named entity recognition (NER) has been extensively studied for the names of genes and gene products but there are few proposed solutions for phenotypes. Phenotype terms are expected to play a key role in inferring gene function in complex heritable diseases but are intrinsically difficult to analyse due to their complex semantics and scale. In contrast to previous approaches we evaluate state-of-the-art techniques involving the fusion of machine learning on a rich feature set with evidence from extant domain knowledge-sources. The techniques are validated on two gold standard collections including a novel annotated collection of 112 abstracts derived from a systematic search of the Online Mendelian Inheritance of Man database for auto-immune diseases. Encouragingly the hybrid model outperforms a HMM, a CRF and a pure knowledge-based method to achieve an F1 of 77.07. Disagreement analysis points to further improvements on this emerging NE task. The annotated corpus and guidelines are available on request.
Introduction
Biomedical named entity recognition (NER) is a computational technique used to identify and classify strings of text (mentions) that designate important concepts in biomedicine. Over the last fourteen years there has been considerable interest in this problem with a variety of generic and entity-specific algorithms applied to extract the names of genes, gene products, cells, chemical compounds and diseases (Fukuda et al., 1998; Rindflesch et al., 1999; Collier et al., 2000; Kazama et al., 2002; Zhou et al., 2003; Settles, 2004; Kim et al., 2004; Leaman and Gonzalez, 2008) . As the first stage in the integrated semantic linking of knowledge between literature and structured databases it is critically important to maximise the effectiveness of this step.
Despite significant progress in NER there is still no one size fits all solution. Barriers arise because of ambiguity in the text and coding schema. Ambiguity in the text comes in various forms according to the semantic type of the entity but can be caused by a lack of standard nomenclatures, extensive and growing nomenclatures for proteins/genes across multiple organisms or the widespread use of abbreviations and descriptive names. For example, (Krauthammer and Nenadic, 2004) illustrate uncontrolled naming in genes with bridge of sevenless (boss) (FlyBase ID FBgn0000206) and Hunter and Bretonnel Cohen (2006) discuss term class ambiguity (e.g. is group a chemical entity or an assemblage of organisms?). Such challenges have led to a variety of proposed solutions involving a wide range of resources. Among these, linguistically annotated corpora such as GENIA (Tateisi et al., 2000; Kim et al., 2003) have proven to be central to the NER solution. However due to the size of the vocabularies involved, annotated corpora by themselves do not provide a complete solution. Researchers have therefore also looked at the rich availability of formally structured biomedical knowledge (ontologies) such as the Unified Medical Language System (UMLS) (Bodenreider et al., 2002) and the Gene Ontology (Gene Ontology Consortium, 2000) . Nevertheless corpora remain a key part of the solution as they provide the contextual evidence that link mentions to terms through the author's intentions. Creating such resources though is time consuming and expensive, especially when annotating new semantic types and relations.
In this paper we focus on the analysis and identification of a new class of entity: phenotypes. Two thoughts motivate this: (1) The database curation community has expressed a wish for full text entity indexing and the inclusion of phenotypes (Dowell et al., 2009; Hirschman et al., 2012) , and (2) Biomedicine is rapidly moving towards full-scale integration of data, opening up the possibility to understand complex heritable diseases caused by genes. Association studies involving phenotypes are considered important to making progress (Lage et al., 2007; Wu et al., 2008) . The ultimate goal of the work we present here is to allow relations mined from sentences such as the one we annotated below to feed into novel hypothesis generation procedures. From Ex 1. the reader can easily infer a relation between IgG1 disorder and three genes/gene products marked as GGP. [anti-double-stranded DNA (anti-dsDNA) antibodies] GG P above 30 U/ml. (Source PMCID: PMC1003566).
Whilst other authors have tried similar approaches for other entity types, none have tried both machine learning and external resource lookup for a class as rich and semantically complex as phenotypes. The key contributions of this paper are: (1) To provide an operational semantics for identifying phenotype candidates in text, (2) To introduce a set of guidelines and an anno-tated corpus based on a selection of 19 clinically significant auto-immune diseases from The Online Mendelian Inheritance of Man (OMIM) (Hamosh et al., 2005) , one of the most widely used gene-disease databases, and (3) To mitigate linguistic variation whilst still meeting the conceptual expectations of biologists we propose a new named entity solution that uses statistical inference and external manually crafted resources. This method is tested on the new corpus and one extant corpus (Khordad et al., 2011 ) that has been used in previously reported experiments.
2 The challenge of phenotypes Freimer and Sabatti (2003) (Robinson and Mundlos, 2010) , phenotypic descriptions still tend to be author/study specific and biological results may go undiscovered if the terms used lie outside an author's immediate research area (Bard and Rhee, 2004) . Again, unlike genes or anatomic structures, phenotypes and their traits are complex concepts and do not constitute a homogeneous class of objects (i.e. a natural kind).
Traits such as 'eye colour', 'blood group', 'hemoglobin concentration' or 'facial grimacing' describe morphological structures, physiological processes and behaviours. When qualities or quantities of traits are used to describe a specific organism then we have phenotypic descriptions, e.g. 'blue eyes', 'blood group AB', 'not having between 13 and 18 gm/dl hemoglobin concentration'.
Traits and phenotypes can apply at all levels of anatomical granularity from chemical structures to cells and organs making it difficult to know where to draw a boundary. Phenotypes can include quantifications that are either specific (e.g. '18 gm/dl') or relative (e.g. 'normal' or 'increased'). Accordingly the first part of this paper deals with specifying exactly what we mean by the concepts of 'phenotype' with reference to current ontological research.
Methods

Schema
We employed two types of entity in our study: gene/gene product (GGP) and bodily feature (BF). GGP is proposed because (a) a subset of these entities are useful for applications that explore gene-phenotype relations, and (b) it allows us to compare our results against the many biomedical NER studies of the past, e.g. (Kim et al., 2004; Rebholz-Schuhmann et al., 2010) . Because of space limitations we will not provide a rigidly formal definition or a taxonomic analysis (Beisswanger et al., 2008) . Future work will explore the relationships between these and other entity types.
In line with BioTop (Beisswanger et al., 2008) , GGP is relatively straightforward to define by the conjunction of (BioTop ID Nucleic Acid Structure) and (BioTop ID Peptide Structure). Our definition of phenotype was taken from the formal analysis in Scheuermann et al. (Scheuermann et al., 2009 ) who define phenotype as 'A (combination of) bodily features(s) of an organism determined by the interaction of its genetic make-up and environment'. It is important to recognise that this definition requires us to know the underlying cause. Since causality is often difficult to establish using narrow contextual evidence of the sort used in NER it seems reasonable that we focus here on identifying bodily features themselves, i.e. phenotype candidates, and then determine causality in another stage of processing.
Definition: A BF (bodily feature) entity is a mention of a bodily quality in an organism. Our definition of bodily features require two caveats (a) in contrast to Khordad et al. (2011) we did not apply a granular cut off at the level of cell, and (b) because of the diversity of bodily features across organisms we took a decision to focus our definition of this entity on mouse as a model organism and human as the most important species. Following the discussion of phenotypes as processes in physiology (Hoehndorf et al., 2012) we include some mentions of processes within the scope of our annotation schema.
Linguistic forms of entities require a number of policy decisions to be made about how to annotate mentions in text. For a class as complex as phenotypes this is a particular consideration. Although more complex approaches exist, for simplicity we make the common assumption here that named entities are 'continuous, non-nested and non-overlapping' (Alex et al., 2007) . As a basic policy we do not allow embedding of entities within our corpus so annotators have to make a choice of entity class based on the longest matching span even though one entity may contain another entity of the same or a different type. We leave to future work consideration of other approaches, e.g. for handling discontinuous entity mentions. Within our guidelines we describe whether specific, generic, underspecified and negatively quantified mentions qualify. A summary of the rule set (available from the first author) is shown in Table 1 . We follow (Magnini et al., 2006) in differentiating between specific, generic and underspecified mentions.
Annotated data sources
Phenominer
The Phenominer version 1 corpus contains 112 abstracts we selected from PubMed Central (PMC). 19 auto-immune diseases were selected from OMIM and from these records citations were then chosen. Diseases include Type 1 diabetes, Grave's disease, Crohn's disease, autoimmune thyroid disease, multiple sclerosis and inflammatory arthritis. In order to ground the article in discussion about both a disease and a phenotype, citations needed to contain the auto-immune disease term and at least one term from either OMIM's free form clinical synopsis field, the Human Phenotype Ontology (HPO) (Robinson and Mundlos, 2010) or the Mammalian Phenotype Ontology (MP) (Smith and Eppig, 2009 ).
Despite being small, the number of annotated abstracts is consistent with several previous specialised studies, e.g. (Suakkaphon et al., 2011; Collier et al., 2000 4 We exclude finite verb forms, infinite verb forms with 'to', verbs in a progressive or perfect aspect, verb phrases, clauses or sentences and any phrase with a relative clause or complement clause. 5 If the negation appears in a noun phrase with an anatomical entity then we generally allow it, e.g. out by the same highly experienced biomedical annotator who had annotated the GENIA corpus. The total number of tokens (sentences) in the corpus is 26,026 (1976) from which there were 1611 GGP entities and 472 BF entities.
KMR
As a basis of comparison we test our methods on the same corpus and tagging model as Khordad et al. (2011) who used a collection of 3784 tokens (120 sentences) with 110 annotated phenotype mentions. This is designated as the KMR corpus. In contrast to the Phenominer corpus sentences in KMR were taken from 4 PubMed papers from the year 2009 in the area of human genetics. Annotation was conducted with reference to the HPO so that a term was tagged as phenotype if it was in the HPO or if it was not in the HPO but its definition showed that it was caused by a genotype (Khordad, 2012 ). Finally we found that there was no cross over of sentences between the Phenominer and KMR corpora.
Models
The full system we developed (designated in the Results as Hybrid) employs machine learning and knowledge-based approaches, combined together with a rule-based Merge module. This is illustrated in Figure 1 . Below we briefly describe its component modules and resources. As a baseline comparison we use Khordad's approach, designated in the Results as Khordad and in Figure 1 as the Rule matching module -see Khordad et al. (2011) . 
Pre-processing
The text collections are passed into a module which splits texts into sentences and tokens. This was done using the OpenNLP library with a Maximum Entropy model 1 . Abbreviation expansion is then done using BioText (Schwartz and Hearst, 2003) to make a list of local abbreviation occurring in each paper which we then replace with their full form. A similar approach is adopted by Khordad in their staged rules.
Machine learning labeler
Within the machine learning module we compare two widely used sequence labeling models: a second order Hidden Markov Models (HMM) (Rabiner and Juang, 1986; Bikel et al., 1997) with Viterbi decoding and a linear chain Conditional Random Fields (CRF) (Lafferty et al., 2001; McDonald and Pereira, 2005) . Both are run as fully supervised models. Class labels for tokens follow the standard BIO system, i.e. each token receives the label O if it is not an NE, B plus the entity name when it starts an entity, and I plus the entity name when it is inside an entity. The main advantage of the CRF over the vanilla HMM is that it estimates the conditional probability distribution over labeled sequences. Both use the freely available Java-based MALLET implementation 2 with default parameters.
Previous research has found that utilizing various features for both the focus word (designated 1 OpenNLP library: http://opennlp.apache.org 2 Mallet: A machine learning for language toolkit: http://mallet.cs.umass.edu/ as w i ) and the surrounding words is crucial to obtain high performance. We take our feature set for BF and GGP labeling from the most typical and effective features used for biomedical NER (Kim et al., 2004) . This is summarised in 1 Part of speech tags are assigned by training the GENIA tagger (Tsuruoka et al., 2005) . 2 The MetaMap semantic tags are chosen from the same group of 15 semantic types chosen by Khordad which are relevant for phenotypes. In addition to the Phenominer and Khordad corpora outlined earlier we also make use of the JNLPBA04 corpus (Kim et al., 2004) for training the GGP labeler. The corpus contains 2000 Medline abstracts selected by a search using terms human, blood cell, transcription factor and then hand annotated for 5 NE classes including RNA, DNA and protein which we merge to form our GGP class. Table 3 summarises the features exploited by the two learner models. 1 This is applied within the 10-fold cross validation framework.
Model Target Phenominer JNLPBA04 LX MM OR CT POS class corpus
1 corpus HMM BF + - + - - + - CRF BF + - + + + + + HMM GGP + + + - - + - CRF GGP + + + + + + +
Knowledge-based labeler
The knowledge-based labeler is divided into Rule matching and Dictionary matching modules. Rule matching is an implementation of Khordad's approach using MetaMap, a subset of the UMLS, the HPO as well as 5 staged heuristics to identify phenotypes. For example, if a phrase has the form: "modifier (from the list of selected modifiers 3 ) +[Anatomy] or [Physiology]" it is a phenotype name. Dictionary matching uses a longest string matching approach to recognise entities from the following resources: BF entities from the HPO (9500 terms describing human phenotypes) and the MP (9162 terms describing mouse phenotypes); GGP entities from the National Center for Biotechnology Information's gene list (9 million gene names). These sources were chosen because of their high standing within the biomedical community.
Merge results
Merge results assigns the final entity label to each token in the corpus by applying the following rules to each source module output. Processing proceeds sentence by sentence.
1. Following Jimeno et al. (2008) we combine the putative entity labels by collecting any entity-specific result that has been proposed by at least one method. This is intended to maximise recall. Thus, the O tag (non-entity label) has the least priority.
2. Based on our ontological analysis of BF and GGP it is often possible for a GGP to form a fully embedded part of a BF mention. 
Evaluation
Metrics
We follow standard metrics of evaluation for the task using F1 as our primary method of comparison 4 . In these experiments matching is calculated using partial matching, i.e. a correct match is recorded when the span of text that is manually annotated in the gold standard corpus and the span of text output as an entity by the NER tagger partially overlap. For example a system annotation of [median cleft lip]/palate would be judged correct for a gold standard annotation of median [cleft lip/palate] . Various authors in the biomedical NER domain such as Kabiljo et al. (2009) have offered a reason for why this or other methods such as sloppy left boundary matching might be preferred to strict matching for genes and proteins. In summary it is thought that with partial matching, for the entity types examined so far, the core part of the entity was in most cases correctly found. In contrast, strict matching places too much faith in arbitrary choices in annotation guidelines.
Experiments on the KMR corpus
Our initial test run is conducted on the KMR corpus with micro-averaged F1 scores shown in Table 4 . Since the corpus only contains phenotype tags no GGP results are shown.
We noted that curiously the results we observed for Khordad's method are slightly down by approximately 3 points of F1 on those given in their article. This appears mostly to affect precision rather than recall and is possibly due to implementation differences such as changes to MetaMap/UMLS. Given the small amount of training data it is not surprising to see the pure machine learning based methods perform relatively poorly (F1:34.07,68.29) against the pure knowledge based approach (F1:83.29). Khordad's staged rule based system with dictionary lookup performs the best (F1:89.58) with the new Hybrid approach a reasonably close second (F1:85.27). It is encouraging though to see that the rule-based combination of the learner and KB outputs add value to the KB-only result. Table 4 : (F)-scores, (R)ecall and (P)recision for each entity type on the KMR corpus using models with partial matching. 1 The KB method uses the Merge module to resolve conflicts. 2 Hybrid refers to the jointly applied system.
Model
Experiments on the Phenominer corpus
For the Phenominer data set we chose to add the GENIA NER tagger trained on the JNLPBA04 corpus as a baseline for GGP. Note that we also combined this corpus data with Phenominer for training the CRF and HMM GGP recogniser. Khordad's method remains as our baseline for phenotypes. Micro-averaged F1 scores are shown in Table 5 . With regard to GGP entities we observed that whilst the GENIA tagger performed robustly (F1:80.89), the Hybrid model appears to significantly outperform this (F1:85.48). The surprising result is that Khordad's method performs relatively poorly (F1:61.38) on BF. Again we try to dig down into the results in the Discussion to get an understanding behind the complex contributing factors. Table 5 : (F)-scores, (R)ecall and (P)recision for each entity type on the Phenominer corpus using models with partial matching. 1 HMM and CRF are trained separately on each entity class and resolved in the Merge module.
Model
2 Training included the JNLPBA04 corpus data for GGPs. 3 The GENIA method is the GENIA NER tagger trained on the GGP entities in the JNLPBA04 corpus. 4 The KB method uses the Merge module to resolve conflicts. 5 Hybrid refers to the jointly applied system.
Discussion
The results on the Phenominer corpus for Hybrid (F1:77.07) on BF are very encouraging and as we hoped demonstrate the strength of combining a mildly context sensitive ML approach with knowledge base lookup. Current NE methods based on a state-of-the-art learning approach such as CRF seem well suited to non-complex NE types such as GGP but maybe less effective for complex entities such as BF. Given the small size of the corpora we must be cautious in this conclusion. With regard to the KB approach for BF, our first impression was that the phenotype resources (HPO and MP) may to some extent lack coverage on the Phenominer corpus but we discuss below why this conclusion maybe too simplistic.
We start our analysis with the necessary observation that the Phenominer and KMR corpora do not offer a strict like-for-like comparison and are therefore most useful to highlight areas of difficulty. Importantly as we noted in Section 2, there is the issue of causality which is implicitly encoded into Khordad's schema and absent from ours. This means that our bodily features may not have a genetic or environmental cause. There is also the issue of granularity: our schema is more complex as it encodes bodily features from the genetic level upwards whereas Khordad's operates on the cellular level upwards. A statistical analysis points to further differences. We found that the average phenotype mention length in the KMR corpus was 1.72 tokens with the longest term being 5 tokens: [hypoplasia of the corpus callosum]. In contrast the average bodily feature mention in Phenominer is 2.89 tokens with the longest being [susceptibility to psoriasis (PS) and psoriatic arthritis (PSA)]. The longest GGP in Phenominer is 16 tokens: [chromosomes 1 (D1S235), 4 (D4S1647), 12 (D12S373), 16 (D16S403) , and 17 (D17S1301))]. Both of these examples from Phenominer indicate structural term issues related to coordination and elipsis which are not easily handled by the simple longest term match approach that we have adopted. Table 6 shows examples of where the Hybrid method disagreed with the KMR corpus. Whilst we have not conducted an in-depth analysis the examples seem reasonable and indicative of differences between the two coding schemas regarding causality of a bodily feature, algorithmic differences in how we prioritize UMLS semantic types related to Disorder and gaps in the knowledge resources.
No. Standard
System Issue Finally we show examples of disagreement for the Hybrid method on the Phenominer corpus in Table 8 . As is common the biomedical literature we noticed a high proportion of coordination issues as well as ambiguity caused by generic terms.
Hybrid Issue 
Conclusions and future work
We have presented new results and analysis that add evidence to how phenotype candidates can be identified using named entity technology. The methods we have employed are aimed at making tractable the annotation of a critical semantics in the scientific literature. To do this we have matched surface forms to their attested forms in domain resources, balanced against contextual evidence from annotations in the scientific literature. The benchmark tests have demonstrated that the Hybrid method performs strongly on both the KMR corpus as well as the new Phenominer corpus. The evidence points towards complementarities between the existing phenotype resources and contextual evidence from annotated corpora.
Our methods have been formulated to be simple, effective and extensible with a focus on providing input to more knowledge intensive techniques downstream that can identify causality. Simplicity though may have sacrified both precision and recall in some cases, e.g. in the issue of coordination, in including generic and underspecified references and in adopting a longest matching approach to annotation.
There is considerable scope for further investigation. F1 might be increased using a machine learning framework such as integer linear programming (Koomen et al., 2005) to resolve hypotheses against multiple constraints much as we have tried to do manually in the Merge module. Coverage might be extended by including disjoint entities and a deeper analysis of embedded entity semantics such as that employed by Alex et al. (2007) . In line with Hoehndorf et al. (2010) future solutions may need to focus on decomposing phenotypes in terms of their internal relations such as qualities 6 .
